General Information of This Antigen
Antigen ID
TAR0CYSHF
Antigen Name
Interleukin-2 receptor subunit alpha (IL2RA)
Gene Name
IL2RA
Gene ID
3559
Synonym
TAC antigen;p55;CD_antigen=CD25
Sequence
MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKS
GSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQAS
LPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQP
QLICTGEMETSQFPGEEKPQASPEGRPESETSCLVTTTDFQIQTEMAATMETSIFTTEYQ
VAVAGCVFLLISVLLLSGLTWQRRQRKSRRTI

    Click to Show/Hide
Function
Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells.

    Click to Show/Hide
Uniprot Entry
IL2RA_HUMAN
HGNC ID
HGNC:6008
KEGG ID
hsa:3559
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
A detuned-affinity anti-CD25 mAb
ADC Name Payload Target Linker ADC Info
PF-08046032 [1]
MMAE
Microtubule (MT)
Mc-Val-Cit-PABC
Camidanlumab
ADC Name Payload Target Linker ADC Info
Camidanlumab tesirine
SG3199 (SC-DR002)
Human deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Undisclosed
ADC Name Payload Target Linker ADC Info
RM-1995
IRDye 700DX
Undisclosed
Undisclosed
Anti-cancer therapy (Philogen/Pfizer) [2]
Undisclosed
Undisclosed
Undisclosed
References
Ref 1 PF-08046032: A Novel, Investigational CD25-Directed Antibody-Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
Ref 2 Philogen announces option and license agreement with Pfizer to develop and commercialize multiple antibody drug conjugates and targeted nanoparticles; 2014